Analystreport

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) had its "buy" rating re-affirmed by analysts at Deutsche Bank AG.

VALEANT PHARMACEUTICALS  (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com